Ennov PV
Ennov provides a unified, AI-powered compliance platform for life sciences, integrating regulatory, quality, clinical, pharmacovigilance, and commercial workflows for 450+ pharmaceutical, biotech, and medical device customers across Europe, the Americas, and Asia.
- Company typePrivate
- Founded2000
- HeadquartersParis, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Ennov PV does
Ennov provides a unified compliance platform for life sciences organizations, integrating Regulatory, Quality, Clinical, Pharmacovigilance, and Commercial functions on a single shared architecture. The platform is built on common components — Ennov Doc (document management), Ennov Data (unified repository with IDMP/xEVMPD support), Ennov Workflow (graphical process engine with 21 CFR Part 11 compliance), Ennov Analytics (dashboards and data warehouse), and Ennov AI (embedded NLP, generative AI, chatbot, and autonomous agents). Solutions are delivered as 100% web-based cloud or on-premises deployments with the ability to switch between them. The company serves 450+ life sciences customers including pharmaceutical, biotech, medical device, animal health, chemical, and food and beverage organizations, with 500,000+ users globally and a 96% maintenance renewal rate.
Headquartered in Paris (Ennov SAS), Ennov was founded in 2000 and operates approximately 420 professionals across France, the US, the UK, India, and through channel partners in China (CloudScientific) and Japan (Matador, DMS). The business model is enterprise SaaS subscription with quote-based pricing for the unified platform and its modules, supplemented by implementation, training, and support services. The company holds ISO 9001 and ISO 27001 certifications and is recognized by Gartner across EDM, RIM, Pharmacovigilance, and eTMF domains. Growth has been driven by a combination of organic product expansion (Ennov 10.3, 10.4, and 11.0) and acquisitions including DocShifter (document automation, 2023) and Calyx's Enterprise Technology division (Liquent InSight, IMPACT CTMS, DataLabs EDC, 2024), with strategic growth investment from Bregal Sagemount and Ardian Growth in 2026.
Ennov PV firmographics
Firmographics- Name
- Ennov PV
- Legal name
- Ennov SAS
- Website
- https://en.ennov.com
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ennov provides a unified, AI-powered compliance platform for life sciences, integrating regulatory, quality, clinical, pharmacovigilance, and commercial workflows for 450+ pharmaceutical, biotech, and medical device customers across Europe, the Americas, and Asia.
- Ownership category
- akta.pro rank
Ennov PV industry classification
Industry- Product category
- Life Sciences Compliance Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Safety/Pharmacovigilance (PV) & Clinical Safety Systems (HLACAOAH)
- akta.pro secondary industries
- Electronic Data Capture (EDC) Platforms (HLACAOAA), Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB), PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited) (HLAGALAJ)
Keywords
Where Ennov PV is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices6 records
Markets served
Ennov PV business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (Unified Compliance Platform): Cloud-based software subscriptions for Regulatory, Quality, Clinical, Pharmacovigilance, and Commercial suites. Available as cloud-based or on-premises deployment with flexible options. Revenue driven by platform licensing and related modules.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels11 records
Ennov PV product offering
Product offeringCore offering
Ennov PV is the pharmacovigilance suite of Ennov's Unified Compliance Platform, providing end-to-end software for collecting, managing, assessing, and reporting human and veterinary adverse events. Built on shared platform components (document management, workflow, data, analytics, AI), it integrates with Regulatory, Quality, and Clinical suites to eliminate data silos across the life sciences product lifecycle. Deployment options include cloud-based SaaS or on-premises, with 21 CFR Part 11 compliance and AI-powered case narrative extraction.
Product overview
Ennov provides a unified compliance platform for life sciences with platform components (Ennov Doc, Ennov Data, Ennov Workflow, Ennov Analytics, Ennov AI) and five solution suites: Regulatory Suite (Ennov Dossier, Ennov RIM, Ennov IDMP, Ennov Artwork, InSight Publishing, InSight RIM), Quality Suite (Ennov Quality Documents, Ennov QMS, Ennov Training), Clinical Suite (Ennov CTMS, IMPACT CTMS, Ennov EDC, DataLabs EDC, MACRO EDC, Ennov eTMF, Ennov RTSM), Pharmacovigilance Suite (Ennov PV), and Commercial Suite. Built on a shared Unified Compliance Platform, all solutions work individually or integrate seamlessly. The company has expanded through acquisitions including Calyx's Enterprise Technology division (Liquent InSight, IMPACT, DataLabs) and DocShifter, and maintains partnerships for AI (CognifAI/CoVigilAI), Japan (Matador), and China (CloudScientific). The platform is 100% web-based with cloud or on-premises deployment options.
Differentiator
Problem solved
Functional benefit
Brands
- Liquent InSight: eCTD publishing and Regulatory Information Management solution acquired from Calyx
- IMPACT CTMS
- DataLabs EDC
- DocShifter
- Ennov AI
Products and services
- Unified Compliance Platform The foundation platform for all Ennov solutions, providing shared components including document management, workflow engine, advanced data repository, analytics, and AI capabilities. Eliminates silos and reduces complexity across regulated processes. 100% web-based, available as cloud-based SaaS or on-premises deployment for life sciences organizations.
Quantifiable outcome
- Delpharm standardized quality across 16 sites with paperless, audit-ready ecosystem
- +7 more outcomes
Companies that use Ennov PV
Customer profileNamed customers7 records
Segments7 records
Ideal customer profiles3 records
Ennov PV technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability6 records
Feature7 records
Ennov PV partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, strategic and supporting.
- CloudScientificcoreEnnov's distribution and services partner in China. CloudScientific provides local access to the Ennov platform along with implementation, support, and consulting services. Founded in 2009, CloudScientific supports more than 1,500 biopharmaceutical and academic clients in China.
- MatadorcoreStrategic partnership bringing Ennov's unified regulatory, quality, and clinical software to the Japanese market. Matador provides local access, deployment, and support fully hosted in Japan with native alignment to evolving EMA and PMDA requirements including eCTD 4.0 readiness.
- CognifAIstrategicStrategic partnership integrating CognifAI's CoVigilAI AI-driven literature monitoring solution into Ennov's pharmacovigilance offering. Enhances literature monitoring activities and compliance with regulatory requirements for PV case extraction from literature.
- ION PharmastrategicStrategic partnership combining ION Pharma's depth of experience in Quality Management Systems (QMS) with Ennov's unified platform. Supports the entire product lifecycle leveraging Ennov Doc, Ennov Process, and Ennov Training.
- DMS (Japan)supportingExisting collaboration with DMS in Japan for regulatory document management and hosting services, further strengthened by the Matador partnership.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Ennov PV competitors and assessment
Company assessmentDirect peers
- ArisGlobal: LifeSphere platform spans pharmacovigilance, regulatory, and quality with strong PV safety database heritage (similar to Ennov PV). Competes head-to-head in PV case management, signal detection, and regulatory information management for mid-to-large pharma.
- Veeva Systems: Veeva Vault is the dominant life sciences CRM and content/regulatory platform serving top-20 pharma globally. Directly competes with Ennov across RIM, eTMF, quality, and pharmacovigilance modules with significantly greater scale and North American enterprise penetration.
- MasterControl: Quality management and document control platform widely deployed across pharma, medical device, and life sciences. Directly competes with Ennov Quality Suite (QMS, Quality Documents, Training) for mid-market regulated compliance customers.
Broad incumbents
- OpenText (Documentum / Regulated Industries): Enterprise document management and content services platform (Documentum heritage) widely used in regulated life sciences. Competes with Ennov Doc and broader document management capabilities, particularly with on-premises deployments in legacy pharma IT environments.
- Cognizant (Life Sciences Digital): Large IT services and digital transformation provider for life sciences, offering managed services and platform implementations around regulatory, clinical, and pharmacovigilance operations. Adjacent competitor as a systems integrator and increasingly as a platform provider.
- IQVIA: Broad life sciences technology and CRO incumbent offering EDC, CTMS, RIM, and PV through its Orchestrated Customer Engagement and R&D Solutions portfolios. Overlaps with Ennov's Clinical Suite (EDC, CTMS, eTMF) and regulatory offerings, though much larger and more diversified.
- Oracle Health Sciences: Oracle's Argus Safety database and Clinical One platform are established leaders in pharmacovigilance safety databases and clinical trial management. Competes directly with Ennov PV (Argus) and Ennov EDC/CTMS offerings within enterprise pharma accounts.
Others
- Calyx (formerly Parexel): Clinical trial technology vendor (formerly Calyx Enterprise Technology, partially acquired by Ennov in 2024). EDC/CTMS/RIM overlap makes it both a competitor in residual product lines and a former business unit now consolidated into Ennov's platform.
Emerging players
- ComplianceQuest: Built-on-Salesforce QMS and compliance platform targeting regulated industries including life sciences. Emerging competitor to Ennov's Quality Suite with a modern cloud-native architecture and CRM-native positioning.
- Dot Compliance: AI-powered QMS and regulatory compliance platform built on Salesforce for pharma, medical device, and biotech. Emerging niche competitor to Ennov Quality and RIM offerings with strong AI/automation positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Ennov PV social profiles
Digital presenceEnnov PV compliance and trust
Trust signalCompliance2 records
Ennov PV financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ennov PV leadership team
Management profileNumber of profiles
Profiles1 record
Ennov PV subsidiaries and ownership
Company hierarchySubsidiaries5 records
Ennov PV funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ennov PV M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ennov PV
What does Ennov PV do?
Ennov PV is the pharmacovigilance suite of Ennov's Unified Compliance Platform, providing end-to-end software for collecting, managing, assessing, and reporting human and veterinary adverse events. Built on shared platform components (document management, workflow, data, analytics, AI), it integrates with Regulatory, Quality, and Clinical suites to eliminate data silos across the life sciences product lifecycle. Deployment options include cloud-based SaaS or on-premises, with 21 CFR Part 11 compliance and AI-powered case narrative extraction.
Is Ennov PV a public or private company?
Ennov PV is a private company. It is classified as venture growth investor backed and is currently operating.
When was Ennov PV founded?
Ennov PV was founded in 2000. It employs 11 to 50 people.
Where is Ennov PV based?
Ennov PV is headquartered in Paris, France, in the Europe region.
How does Ennov PV make money?
One revenue line is on record: saaS Subscription (Unified Compliance Platform).
Who are Ennov PV's main competitors?
Direct peers on record are ArisGlobal, Veeva Systems and MasterControl. Broad incumbents are OpenText (Documentum / Regulated Industries), Cognizant (Life Sciences Digital), IQVIA and Oracle Health Sciences. Calyx (formerly Parexel) is listed as an others. Emerging players are ComplianceQuest and Dot Compliance.
Does Ennov PV have an API?
Yes. REST API for advanced integration to external systems. Ennov Workflow mentions that REST API enables advanced integration to external systems. The platform is 100% web-based with cloud-based or on-premises deployment options.
What industry is Ennov PV in?
Ennov PV's product category is Life Sciences Compliance Software. Its primary akta.pro industry code is HLACAOAH, Safety/Pharmacovigilance (PV) & Clinical Safety Systems, with a secondary code of HLACAOAA, Electronic Data Capture (EDC) Platforms. Its NAICS code is 5132 and its SIC code is 7372.